Co-Authors
This is a "connection" page, showing publications co-authored by Claudio Punzo and Phillip Tai.
Connection Strength
0.513
-
Cui M, Su Q, Yip M, McGowan J, Punzo C, Gao G, Tai PWL. The AAV2.7m8 capsid packages a higher degree of heterogeneous vector genomes than AAV2. Gene Ther. 2024 09; 31(9-10):489-498.
Score: 0.219
-
Cheng SY, Luo Y, Malachi A, Ko J, Su Q, Xie J, Tian B, Lin H, Ke X, Zheng Q, Tai PWL, Gao G, Punzo C. Low-Dose Recombinant Adeno-Associated Virus-Mediated Inhibition of Vascular Endothelial Growth Factor Can Treat Neovascular Pathologies Without Inducing Retinal Vasculitis. Hum Gene Ther. 2021 07; 32(13-14):649-666.
Score: 0.177
-
Cui M, Cheng SY, Liang J, McGowan J, Xu M, Xu G, Luo L, Wu J, Harman CD, Jacobson AL, Kapeller LE, Mayes MA, Namkung S, Sharma T, Leland TB, Zhang F, Yip M, Rossmiller B, Xue T, Chen X, Boonying W, Lotun A, Wang D, Su Q, Xie J, Wei Y, Rothstein AM, Gregory-Ksander MS, Komaromy A, Tian B, Lin H, Punzo C, Tai PWL, Gao G. Modification of the VP1u region boosts transduction of adeno-associated virus vectors for ocular gene therapy. Mol Ther. 2026 May 06; 34(5):2781-2800.
Score: 0.061
-
Wang JH, Cui M, Liu H, Guo P, McGowan J, Cheng SY, Gessler DJ, Xie J, Punzo C, Tai PWL, Gao G. Cell-penetrating peptide-grafted AAV2 capsids for improved retinal delivery via intravitreal injection. Mol Ther Methods Clin Dev. 2025 Mar 13; 33(1):101426.
Score: 0.057